Ken Cacciatore
Stock Analyst
(n/a)
# 2,782
Out of 4,648 analysts
14
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Ken Cacciatore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Outperform | $65 → $50 | $8.72 | +473.72% | 2 | Aug 9, 2023 | |
| BHC Bausch Health Companies | Downgrades: Market Perform | n/a | $9.34 | - | 1 | Jun 16, 2023 | |
| TAK Takeda Pharmaceutical | Maintains: Outperform | $30 → $20 | $14.10 | +41.84% | 4 | May 16, 2023 | |
| SCPH scPharmaceuticals | Initiates: Outperform | $25 | $4.02 | +521.89% | 1 | Dec 1, 2022 | |
| BLCO Bausch + Lomb | Initiates: Outperform | $35 | $19.98 | +75.22% | 1 | May 11, 2022 | |
| MOLN Molecular Partners AG | Initiates: Outperform | $50 | $6.05 | +726.45% | 1 | Jul 13, 2021 | |
| TARA Protara Therapeutics | Initiates: Outperform | $50 | $2.57 | +1,845.53% | 1 | Oct 19, 2020 | |
| BHVN Biohaven | Initiates: Outperform | $45 | $49.84 | -9.71% | 1 | Apr 17, 2020 | |
| AMRN Amarin Corporation | Initiates: Outperform | $23 | $0.61 | +3,671.11% | 1 | Mar 2, 2020 | |
| OPTN OptiNose | Initiates: Outperform | $25 | $0.68 | +3,575.93% | 1 | Dec 18, 2019 |
Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65 → $50
Current: $8.72
Upside: +473.72%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $9.34
Upside: -
Takeda Pharmaceutical
May 16, 2023
Maintains: Outperform
Price Target: $30 → $20
Current: $14.10
Upside: +41.84%
scPharmaceuticals
Dec 1, 2022
Initiates: Outperform
Price Target: $25
Current: $4.02
Upside: +521.89%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $19.98
Upside: +75.22%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $6.05
Upside: +726.45%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $2.57
Upside: +1,845.53%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $49.84
Upside: -9.71%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $23
Current: $0.61
Upside: +3,671.11%
OptiNose
Dec 18, 2019
Initiates: Outperform
Price Target: $25
Current: $0.68
Upside: +3,575.93%